Manganese therapy for dyslipidemia and plaque reversal in murine models

导出原文传递学术成果认领

摘要Dear Editor,Cardiovascular diseases(CVDs)and related metabolic disorders continue to rank as the leading cause of human mortality,caus-ing＞20 million deaths per year worldwide.Hyperlipidemia,or ele-vated circulating lipid levels,stands out as the primary risk factor of CVDs,notably through the inception of atherosclerosis[1].

作者 Yawei Wang ^[1] Xin Feng ^[2] Wenjing Zhou ^[3] Runze Huang ^[3] Yating Hu ^[3] Hui Hui ^[2] Jie Tian ^[4] Xiao Wang ^[3] Xiao-Wei Chen ^[5] 学术成果认领

作者单位 State Key Laboratory of Membrane Biology,Peking University,Beijing 100871,China;PKU-THU Joint Center for Life Sciences,Peking University,Beijing 100871,China ^[1] CAS Key Laboratory of Molecular Imaging,Institute of Automation,Chinese Academy of Sciences,Beijing 100190,China;Beijing Key Laboratory of Molecular Imaging,Beijing 100190,China;School of Artificial Intelligence,University of Chinese Academy of Sciences,Beijing 100080,China ^[2] State Key Laboratory of Membrane Biology,Peking University,Beijing 100871,China;Institute of Molecular Medicine,College of Future Technology,Peking University,Beijing 100871,China ^[3] CAS Key Laboratory of Molecular Imaging,Institute of Automation,Chinese Academy of Sciences,Beijing 100190,China;Beijing Key Laboratory of Molecular Imaging,Beijing 100190,China ^[4] State Key Laboratory of Membrane Biology,Peking University,Beijing 100871,China;Institute of Molecular Medicine,College of Future Technology,Peking University,Beijing 100871,China;PKU-THU Joint Center for Life Sciences,Peking University,Beijing 100871,China ^[5]

栏目名称 LETTERS

DOI 10.1093/lifemeta/load040

发布时间 2024-06-04